Sallie Swann
Nashville-based commercial real estate brokerage, development and design firm Southeast Venture has hired Sallie Swann as a commercial real estate broker.
Swann (pictured) will focus on industrial leasing and sales, according to a release.
Swann joins Southeast Venture from CBRE’s Nashville office, where she worked for three years as an associate on the company’s advisory and transaction services team, specializing in industrial leasing and property sales. Previously, she spent four years as an attorney, most recently at Parks Acres Inc. and Gullett Sanford Robinson & Martin before that, serving clients primarily in the real estate, business and corporate sectors.
A transgender Navy sailor s 7-year odyssey, and the military career that could end - The Virginian-Pilot
pilotonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pilotonline.com Daily Mail and Mail on Sunday newspapers.
The Globe and Mail Adrienne Matei Published January 23, 2021
Hiraman/iStockPhoto / Getty Images
When I was young, I was crafty. Not in the “sneaky” sense of the word (although I was that, too) but literally – I did crafts, prodigiously. My childhood hobbies included bracelet weaving, beading and bug collecting. I collected Klutz books, those chunky girlhood manuals that advised one on skills such as hair braiding and face painting, and I learned the art of making balloon animals, for which I retain the bizarre muscle memory.
These DIY proclivities persisted into my teens, when I painted on, ripped up and re-stitched half of my clothes; for a while, I thought I might go to art school. But I didn’t. Instead, when I went to university, I forgot about the things I used to do in favour of buckling down and developing some vices. By the time I finished my undergraduate degree, my interest in hobbies, crafts, or creating much of anything with my hands had pretty much evapora
Woodcock’s extraordinary expertise will ensure excellent stewardship in her role as Acting FDA Commissioner PHILADELPHIA The American Association for Cancer Research (AACR), which consists of more than 47,000 laboratory, translational, and clinical researchers; other health care professionals; population scientists; and patient advocates, strongly supports President Biden’s decision to appoint Janet Woodcock, MD, as acting commissioner of the U.S. Food and Drug Administration (FDA). “We look forward to working with Dr. Woodcock and her dedicated colleagues at the FDA to ensure the approval of safe and effective treatments for patients with cancer,” said AACR President Antoni Ribas, MD, PhD, professor of Medicine at the David Geffen School of Medicine at the University of California Los Angeles, and director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program. “Throughout her more than three decades of stellar service at the FDA, Dr. Wood
vimarsana © 2020. All Rights Reserved.